<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25010330</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection.</ArticleTitle><Pagination><StartPage>e102025</StartPage><MedlinePgn>e102025</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e102025</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0102025</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Patients &lt;18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4(+)CD25(+)Foxp3+ and CD4(+)Foxp3(+) T cells compared with patients with HFMD or BE. The expression frequency of CD4-CD8- was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4+Foxp3+ increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shih-Min</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine College of Medicine, National Cheng Kung University and Hospital, Tainan, Taiwan; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>I-Chun</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yu-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ching-Chuan</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, National Cheng Kung University and Hospital, Tainan, Taiwan; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015704">CD4 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C418974">FOXP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>E0399OZS9N</RegistryNumber><NameOfSubstance UI="D000242">Cyclic AMP</NameOfSubstance></Chemical><Chemical><RegistryNumber>JU9YAX04C7</RegistryNumber><NameOfSubstance UI="D020105">Milrinone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015704" MajorTopicYN="N">CD4 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000242" MajorTopicYN="N">Cyclic AMP</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016130" MajorTopicYN="N">Immunophenotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020105" MajorTopicYN="N">Milrinone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050378" MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>7</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25010330</ArticleId><ArticleId IdType="pmc">PMC4092122</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0102025</ArticleId><ArticleId IdType="pii">PONE-D-14-15286</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang SM, Liu CC (2014) Enterovirus 71: epidemiology, pathogenesis and vaccine. Expert Rev Anti-Infect Ther 12: 447&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">24579906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Ho TS, Lin HC, Lei HY, Wang JR, et al. (2012) Reemerging of enterovirus 71 in Taiwan: the age impact on disease severity. Eur J Clin Microbiol Infect Dis 31: 1219&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pubmed">21983920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, et al. (1999) Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29: 184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, et al. (2003) Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188: 564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang MC, Wu JM, Chen CT, et al. (2005) Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol 39: 219&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">15635619</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipley JB, Tolman D, Hastillo A, Hess ML (1996) Review: milrinone: basic and clinical pharmacology and acute and chronic management. Am J Med Sci 311: 286&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">8659556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashida N, Tomoeda H, Oda T, Tayama E, Chihara S, et al. (1999) Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass. Ann Thorac Surg 68: 1661&#x2013;1667.</Citation><ArticleIdList><ArticleId IdType="pubmed">10585039</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell RE, Jenkins LP, Howell DE (1995) Inhibition of lipopolysaccharide induced pulmonary edema by isozyme selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther 275: 703&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">7473157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamarche Y, Malo O, Thorin E, Denault A, Carrier M, et al. (2005) Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 130: 83&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">15999045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentschel T, Yin N, Riad A, Habbazettl H, Weimann J, et al. (2007) Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. Anesthesiol 106: 124&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">17197854</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronoff DM, Canetti C, Serezani CH, Luo M, Peters-Golden M (2005) Cutting edge: Macrophage inhibition by cyclic AMP (cAMP): Differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol 174: 595&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">15634874</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt J, Hatzelmann A, Fleissner S, Heimann-Weitschat I, Lindstaedt R, et al. (1995) Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine TH2-type T cell clone D10.G4.1. Immunopharmacol 30: 191&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">8557518</ArticleId></ArticleIdList></Reference><Reference><Citation>Glavas NA, Ostenson C, Schaefer JB, Vasta V, Beavo JA (2001) T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc Natl Acad Sci USA 98: 6319&#x2013;6324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC33466</ArticleId><ArticleId IdType="pubmed">11371644</ArticleId></ArticleIdList></Reference><Reference><Citation>Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, et al. (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3008159</ArticleId><ArticleId IdType="pubmed">17237765</ArticleId></ArticleIdList></Reference><Reference><Citation>Vendetti S, Patrizio M, Riccomi A, Magistris MTD (2006) Human CD4+ T lymphocytes with increased intracellular cAMP levels exert regulatory functions by releasing extracellular cAMP. J Leukoc Biol 80: 880&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pubmed">16888088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nature Immunol 6: 345&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">15785760</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK (2001) Type 1 T regulatory cells. Immunol Rev 182: 68&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">11722624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsdell F (2003) Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19: 165&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932350</ArticleId></ArticleIdList></Reference><Reference><Citation>La Cava A (2008) Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun Rev 8: 83&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2583407</ArticleId><ArticleId IdType="pubmed">18771756</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Chess L (2004) An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 114: 1198&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC524238</ArticleId><ArticleId IdType="pubmed">15520848</ArticleId></ArticleIdList></Reference><Reference><Citation>Paust S, Cantor H (2005) Regulatory T cells and autoimmune diseases. Immunol Rev 204: 195&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">15790360</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, et al. (2001) Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 193: 1285&#x2013;1294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193380</ArticleId><ArticleId IdType="pubmed">11390435</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, et al. (2010) Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Eur J Immunol 40: 2528&#x2013;2538.</Citation><ArticleIdList><ArticleId IdType="pubmed">20690182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZX, Yang L, Young KJ, Du Temple B, Zhang L (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 6: 782&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">10888927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan Fu, CL Chen, YX He, Zu Y, Cao D, et al. (2009) Changes of immune function in patients with enterovirus 71 infection. Chin J Pediatr 47: 829&#x2013;834.</Citation><ArticleIdList><ArticleId IdType="pubmed">20078993</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, et al. (2009) Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31: 772&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2814877</ArticleId><ArticleId IdType="pubmed">19896394</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, et al. (2002) Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr 91: 632&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang MC, Su LY, Lin HC, et al. (2006) Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol 37: 47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">16861032</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhn K, Simmons CP, Moran E, Dung NT, Chau TN, et al. (2007) Increased frequencies of CD4+CD25high regulatory T cells in acute dengue infection. J Exp Med 204: 979&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118571</ArticleId><ArticleId IdType="pubmed">17452519</ArticleId></ArticleIdList></Reference><Reference><Citation>Strober S, Dejbachsh-Jones S, Van Vlasselaer P, Duwe G, Salimi S, et al. (1989) Cloned natural suppressor cell lines express the CD3+CD4&#x2212;CD8&#x2212; surface phenotype and the alpha, beta heterodimer of the T cell antigen receptor. J Immunol 143: 1118&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">2526181</ArticleId></ArticleIdList></Reference><Reference><Citation>Carulli G, Lagomarsini G, Azzara A, Testi R, Riccioni R, et al. (2004) Expansion of TcR alphabeta+CD3+CD4&#x2212;CD8&#x2212; (CD4/CD8 double-negative) T lymphocytes in a case of staphylococcal toxic shock syndrome. Acta Haematol 111: 163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">15034239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathiot ND, Krueger R, French MA, Price P (2001) Percentage of CD3+CD4-CD8-&#x3b3;&#x3b4; TCR- T cells is increased HIV disease. AIDS Res Hum Retroviruses 17: 977&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">11461683</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowley SC, Hamilton E, Frelinger JA, Su J, Forman J, et al. (2005) CD4&#x2212;CD8&#x2212; T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med 202: 309&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212999</ArticleId><ArticleId IdType="pubmed">16027239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL (2010) Lung CD4&#x2212;CD8&#x2212; double-negative T cells are prominent producers of IL-17A and IFN-&#x3b3; during primary respiratory murine infection with Francisella tularensis live vaccine strain. J Immunol 184: 5791&#x2013;5801.</Citation><ArticleIdList><ArticleId IdType="pubmed">20393138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi CY, Khanh TH, Thoa LPK, Tseng FC, Wang SM, et al. (2013) Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial. Crit Care Med 41: 1754&#x2013;1760.</Citation><ArticleIdList><ArticleId IdType="pubmed">23685637</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczypka M, Obmi&#xf1;ska-Mrukowicz B (2010) Modulating effects of nonselective and selective phosphodiesterase inhibitors on lymphocyte subsets and humoral immune response in mice. Pharmacol Rep 62: 1148&#x2013;1158.</Citation><ArticleIdList><ArticleId IdType="pubmed">21273672</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga K, Takaesu G, Yoshida R, Nakaya M, Kobayashi T, et al. (2009) Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-fos protein. Immunity 30: 372&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">19285436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekkers BG, Rack&#xe9; K, Schmidt M (2013) Distinct PKA and Epac compartmentalization in airway function and plasticity. Pharmacol Ther 137: 248&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">23089371</ArticleId></ArticleIdList></Reference><Reference><Citation>Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, et al. (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204: 1303&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118605</ArticleId><ArticleId IdType="pubmed">17502663</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M, Vaeth M, Scheel T, Grabbe S, Baumgrass R, et al. (2012) Repression of cyclic adenosine monophosphate upregulation disarms and expands human regulatory T cells. J Immunol 188: 1091&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">22190184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KD, Yang MY, Li CC, Lin SF, Chong MC, et al. (2001) Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis 183: 850&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237800</ArticleId></ArticleIdList></Reference><Reference><Citation>Vendetti S, Riccomi A, Sacchi A, Gatta L, Pioli C, et al. (2002) Cyclic adenosine 5-monophosphate and calcium induce CD152 (CTLA-4) up-regulation in resting CD4 T lymphocytes. J Immunol 169: 6231&#x2013;6235.</Citation><ArticleIdList><ArticleId IdType="pubmed">12444128</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>